Autopsy report · NCT00664430

Efficacy and Safety of Paricalcitol on the Treatment of Secondary Hyperparathyroidism in Calcitriol Resistant Dialysis Subjects

“Low enrollment rate”

The sponsor’s own words in the registry.

Life of this trial

• Registered 9 months before it started.
• Ran for about 5 months before it stopped.
• 13 participants enrolled.
• Results were posted on the registry 1 year 2 months after it ended.

Vital statistics

Status

Terminated

Phase

Phase 4

Sponsor

Abbott

Sponsor type

Industry

Conditions

Secondary Hyperparathyroidism; Dialysis

Interventions

Calcitriol; Paricalcitol

Participants

13

Sites

2

Countries

Brazil

Trials that died the same way

• Targeted Pharmacological and Behavioral Treatments for Smoking in Schizophrenia Study 1
  “Low rate of enrollment” (97% match in meaning)
• Trial of Supplemental Parenteral Nutrition in Under and Over Weight Critically Ill Patients (TOP-UP)
  “Low enrollment rates.” (91% match in meaning)
• The Use of Proton Pump Inhibitor on the Prevention of Gastric Cancer Bleeding
  “Low enroll rate” (90% match in meaning)
• Effect of Holofiber Socks and Bedding on Pain and Quality of Sleep in Subjects With Chronic Foot Pain
  “Low enrollment” (89% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.